DMT

What DMT Is

N,N-Dimethyltryptamine (DMT) is a tryptamine alkaloid produced by hundreds of plant species across dozens of botanical families, as well as by marine organisms and certain invertebrates. It is also synthesised endogenously in humans and other mammals (detectable in blood, urine, and cerebrospinal fluid) though the physiological significance of endogenous DMT remains a subject of active investigation. Its biosynthesis in plants typically occurs as a chemical defence metabolite, though its functional roles vary across species and ecological contexts.

DMT is the primary psychoactive component of ayahuasca when combined with MAOI-containing plants, but the two contexts, inhaled/vaporised DMT and oral DMT in ayahuasca, produce experiences so different in duration, intensity, and phenomenological character that they are effectively distinct practices requiring separate consideration. This page addresses inhaled and vaporised N,N-DMT; see the Ayahuasca page for oral DMT in ceremonial context.

DMT should not be confused with 5-MeO-DMT, a structurally related but pharmacologically and phenomenologically distinct compound found in the Sonoran Desert toad and several plant species. The two compounds share a name suffix and a tryptamine skeleton but produce profoundly different experiences.

DMT is typically encountered as a white to yellow crystalline or waxy solid extracted from plant material (most commonly Mimosa hostilis root bark, Acacia confusa, or Psychotria viridis leaves). Extraction chemistry is widely documented in harm reduction literature. Purity and form vary; “freebase” DMT is the form most readily vaporised, while DMT fumarate and other salts are less volatile and require higher temperatures or alternative administration routes.

Where DMT Comes From

DMT occurs across an extraordinary range of the living world, in hundreds of plant species from unrelated families, in some marine organisms, and in trace amounts in mammals including humans. Almost none of that breadth is relevant to how people actually obtain it. In practice, nearly all DMT in circulation comes from the root bark of a small number of plants, extracted with household chemistry.

The dominant source worldwide is Mimosa tenuiflora, still widely sold under its older name Mimosa hostilis, a fast-growing tree of Brazil and Mexico whose root bark carries a high alkaloid content. In East Asia and Hawaii, Acacia confusa root bark plays the same role, and in Australia several native acacias do. Psychotria viridis leaf contains DMT too but at much lower concentration, which is why it goes into ayahuasca rather than into extractions.

One sourcing point deserves attention. Anadenanthera seeds, used traditionally as yopo and cohoba snuffs, are sometimes described as a DMT source, and that description is misleading. Their dominant alkaloid by a wide margin is bufotenine, with DMT and 5-MeO-DMT present only in small amounts. Anything extracted from them is largely bufotenine, which has a markedly different and more physically unpleasant profile, and it also carries a trace of 5-MeO-DMT that plant material sold as a DMT source should not contain at all. Given the dose difference between DMT and 5-MeO, this is worth knowing rather than a botanical footnote.

Extraction, and what colour tells you

DMT is separated from plant material by acid-base extraction, a documented procedure requiring no specialist equipment, which is why the compound is usually extracted rather than synthesised. Synthesis is possible and less common, since plant material is cheap and in many jurisdictions the bark itself is sold openly for dyeing and tanning.

The product ranges from off-white through yellow to orange or reddish, and people read a great deal into that colour that it does not support. Colour mostly reflects the source plant and how thoroughly the extraction was cleaned. Mimosa carries pigments and plant fats that tint the result yellow or orange, while a well-recrystallised or acacia-derived product tends paler. What colour does indicate, indirectly, is purity by weight: a waxy orange product contains more non-DMT material than a clean crystal, so the same measured amount delivers less DMT. Colour is a rough hint about concentration. It is not an identity test, and it cannot tell you whether what you have is DMT at all.

Form matters for whether it will work. Freebase DMT vaporises at a workable temperature. DMT fumarate and other salts do not vaporise well and are intended for other routes, so salt sold for smoking will largely be wasted.

Changa

Changa is DMT absorbed into a smokable herb blend, almost always including a plant containing an MAOI, typically Syrian rue or Banisteriopsis caapi leaf. It is easier to smoke than crystal and produces a slower onset and a longer, somewhat gentler experience. Two things follow that people frequently miss. The proportion of DMT in a given blend is unknown unless the maker measured it, so dosing changa by eye is guesswork. And the MAOI component brings the interaction risks that apply to ayahuasca, which plain vaporised DMT does not carry. Changa is not simply a convenient format for the same substance.

History & Cultural Roots

Indigenous peoples across the Amazon basin, the Caribbean, and parts of South America have used DMT-containing plant preparations for ceremonial, healing, and divinatory purposes for thousands of years. Archaeological evidence for snuffed plant preparations containing DMT (and 5-MeO-DMT) dates to at least 3000 BCE in the Atacama Desert of northern Chile. In the Caribbean and parts of South America, cohoba snuff (prepared from Anadenanthera peregrina seeds, which contain DMT alongside bufotenine) was central to Taíno and Arawakan ceremonial practices documented by early European colonisers.

In the Amazon, DMT-containing plants (Psychotria viridis, Diplopterys cabrerana) function primarily as admixtures to ayahuasca rather than being used in isolation. Smoked DMT as a standalone practice is largely a Western innovation: Richard Evans Schultes documented DMT in Anadenanthera peregrina (then classified as Piptadenia peregrina) in the 1940s, and the synthesis of DMT was accomplished by Manske in 1931. Its psychoactivity was discovered independently by Stephen Szára in 1956. William Burroughs, Terence McKenna, and the counterculture catalysed its spread in Western subcultures from the 1960s onward. McKenna’s descriptions, popularised through his lectures and writings, established much of the cultural mythology around DMT: machine elves, hyperspace, the “spirit molecule.” Rick Strassman’s clinical research at the University of New Mexico in the early 1990s was the first human trials of DMT in the United States, producing findings (and a popular book) that significantly shaped subsequent Western perception of the compound.

How DMT Works

Receptor pharmacology

DMT acts primarily as an agonist at 5-HT2A receptors (the same primary receptor target as psilocin, LSD, and mescaline) producing the characteristic features of classic psychedelic experience. It also shows significant activity at 5-HT2C receptors, sigma-1 receptors (thought to contribute to its unusual experiential quality and possibly its neuroprotective effects), trace amine-associated receptors (TAARs), and various other receptor subtypes. Its interaction with sigma-1 receptors, in particular, has generated scientific interest: sigma-1 receptors modulate neuroinflammation, neural plasticity, and cellular stress responses, and some researchers propose that this mechanism may contribute to both DMT’s distinctive phenomenology and potential therapeutic effects.

When inhaled, DMT produces peak plasma concentrations within 2–3 minutes and is rapidly metabolised by monoamine oxidase (MAO) enzymes, particularly MAO-A, both peripherally and in the brain. This rapid metabolism is responsible for the characteristically short duration of smoked DMT. When MAO is inhibited (as in ayahuasca, where MAOI-containing plants are combined with DMT-containing plants), oral DMT becomes active and the experience extends to 4–6 hours. Without MAO inhibition, orally consumed DMT is almost entirely metabolised before reaching the brain and produces no psychoactive effect.

Endogenous DMT

The detection of DMT in mammalian tissue (including human blood, urine, and the pineal gland) has fuelled longstanding speculation about endogenous roles: theories about DMT and near-death experiences, dreaming, or mystical states. The “spirit molecule” hypothesis proposed by Rick Strassman suggests endogenous DMT may play a role in extraordinary states of consciousness. This remains speculative: the concentrations at which endogenous DMT is detected are orders of magnitude below those required for psychoactive effects under normal conditions, and its endogenous function is not established. The sigma-1 receptor may be the more relevant target for endogenous DMT at physiological concentrations.

Effects

Onset and intensity

Inhaled DMT is among the fastest-acting psychoactive compounds known. Effects begin within seconds of inhalation, reach full intensity within 2–5 minutes, and return to baseline within 15–30 minutes in most cases. The rapidity and intensity of onset is one of DMT’s most distinctive (and, for some people, most challenging) features. There is typically very little transitional space between sober consciousness and the peak experience; the compound takes hold before most people have time to orient to what is happening.

The experiential character of a significant DMT dose is unlike any other commonly used psychedelic. Common reports include a complete dissolution of ordinary physical and temporal reality; immersion in a highly structured alternate space, often described as more real than ordinary consciousness; encounters with autonomous entities (described variously as machine elves, teachers, interdimensional beings, or presences of profound otherness) that communicate, often without language; geometric and architectural visuals of extraordinary complexity and apparent purpose; and a sense of noetic certainty (the felt conviction that one is perceiving something real and important) that can be disorienting to integrate afterward.

Entity encounters

Entity encounters are reported by a large proportion of DMT users in survey research and are among the most discussed and debated phenomena in psychedelic science. Timmermann and colleagues (2019) found that 58% of participants in a survey study reported encountering entities, and that most described the experience as the most meaningful of their lives. The ontological status of these entities (whether they represent aspects of the individual’s unconscious, products of neurological reorganisation, or something else) is genuinely contested and not resolved by current science. Committed positions in either direction (they are “just” neural artefacts, or they are objectively real) outrun the evidence. The phenomenological reality of these encounters, their experienced vividness and significance, is not in doubt.

Duration note

Standard smoked DMT experience: 15–30 minutes to baseline. Extended-state DMT (ESDMT) protocols, delivering DMT via intravenous infusion at sub-breakthrough doses for extended periods, have been investigated by Timmermann and colleagues at Imperial College London and produce sustained altered states lasting up to several hours, allowing more structured observation and therapeutic use. Oral DMT with MAOI (ayahuasca): 4–6 hours.

Dosage & Routes

These ranges apply to smoked/vaporised freebase DMT. Potency of extract varies; start lower than these ranges with unfamiliar material.

Administration methods

DMT freebase has a low boiling point and degrades quickly at high temperatures, standard combustion pipes destroy most of the compound. Effective methods include: vaporisation using a purpose-designed vaporiser or a “machine” (glass bulb vaporiser); the “sandwich” method (sandwiching DMT between layers of inert herb in a pipe, avoiding direct flame contact); and infusion devices. Intravenous administration is used in clinical research settings. Snorting DMT salts (fumarate or hydrochloride) is painful and poorly absorbed but produces a slower, lower-intensity effect. Plugging (rectal administration) of DMT salts is also used in harm reduction contexts for more gradual onset.

Proper vaporisation technique is critical. Users who inhale at too low a temperature or too quickly may not achieve an effective dose and may waste significant material while exposing themselves to partial effects that produce anxiety without the full experiential context. The typical instruction is to inhale slowly, hold briefly, and aim for 2–3 inhalations to achieve a breakthrough dose, though technique varies by device.

DMT Compared to 5-MeO-DMT

These two compounds are confused more often than any other pair on this site, and the confusion is the most dangerous one available. They share a name, a tryptamine skeleton, and a reputation for brevity and intensity. They differ in active dose by roughly a factor of three, in character almost completely, and in risk profile substantially.

One further practical difference: people often describe N,N-DMT as something they can return to and explore, while 5-MeO tends to be approached far more sparingly, with a guide, and with much more preparation. Experience with one gives you little useful intuition about the other.

What the Research Shows

DMT research has accelerated significantly in the past decade. Strassman’s foundational clinical work in the 1990s documented the phenomenological character of IV DMT administration systematically for the first time. Timmermann and colleagues at Imperial College London have led the most rigorous contemporary research: their work characterises the neural correlates of the DMT state using EEG and fMRI, documents entity encounter prevalence, explores the theta-burst EEG signature unique to DMT, and investigates DMT-induced neuroplasticity mechanisms. A clinical trial examining IV DMT for major depressive disorder is underway at Imperial, making DMT one of several psychedelics now in formal therapeutic investigation.

Survey research has established population-level patterns: Gallimore and Strassman (2016) proposed that DMT induces a “reality switch”, a functional replacement of ordinary perceptual reality, rather than overlaying it, distinguishing it phenomenologically from other psychedelics. Entity encounter surveys (Davis et al., 2020; Timmermann et al., 2019) establish prevalence rates and find that most experiencers rate entities as conscious, benevolent, and as sources of insights or information. The meaning-making dimensions of DMT are substantial and require integration frameworks that can hold material of unusual experiential intensity.

Risks & Contraindications

DMT’s short duration contributes to a relatively contained safety profile, the window of incapacitation is brief, and physiological effects (mild increases in blood pressure and heart rate) are transient. There are no documented deaths from DMT toxicity alone at commonly used doses. The primary risks are:

Psychological overwhelm: The rapidity and totality of DMT’s onset leaves no transition time. People who are psychologically unprepared for complete ego dissolution and reality replacement may experience terror. Having a trusted sitter present is strongly recommended for any breakthrough dose.

Physical safety during the experience: During a breakthrough DMT experience, physical coordination is temporarily absent. Users must be seated or lying down in a safe environment; attempting to stand or move during peak effects carries a real fall risk.

Serotonin syndrome with MAOIs: Combining smoked DMT with MAO inhibitors, either pharmaceutical MAOIs or the MAOI-containing plants used in ayahuasca, is dangerous and can produce serotonin syndrome. Syrian rue (Peganum harmala) is sometimes smoked alongside DMT to extend its duration; this combination carries serotonin syndrome risk and must be approached with care. Pharmaceutical MAOIs are an absolute contraindication.

Cardiovascular: Blood pressure and heart rate increase transiently. Individuals with significant cardiac disease, hypertension, or risk factors should assess this carefully before use.

Personal or family history of psychosis: As with all classic psychedelics, this is a contraindication.

Integration challenges: The ontological disruption produced by a breakthrough DMT experience, particularly entity encounters, can be genuinely disorienting to integrate within ordinary frameworks of reality and meaning. Having access to integration support from someone familiar with non-ordinary states is valuable, particularly after intense experiences.

Verifying What You Have

DMT has one verification problem that matters far more than the rest, and it is not adulteration. Extracted DMT is usually what it is claimed to be, because the people making it are generally making it for themselves and their friends rather than for profit. The problem is telling it apart from its close relative.

Reagents cannot separate DMT from 5-MeO-DMT

Ehrlich reagent turns purple in the presence of indole alkaloids, and both N,N-DMT and 5-MeO-DMT are indoles. A purple Ehrlich confirms that you have an indole of some sort and tells you nothing about which one. Given the dose difference between the two, this is the single most consequential limitation of home testing anywhere on this site. Treat a positive Ehrlich as ruling out a non-indole substitution and nothing more.

Two weak checks are still worth having. N,N-DMT has a strong and distinctive smell, most often compared to new plastic or mothballs, which 5-MeO does not share, so an odourless white crystal sold as DMT deserves scepticism. And the dose arithmetic itself is informative: material that produces a full experience at well under 20 mg is behaving like 5-MeO rather than DMT, which is a reason to stop rather than an interesting observation.

Purity, weight, and the colour question

As explained in where it comes from, colour largely reflects the source plant and how well the extraction was cleaned. The practical consequence is that a waxy orange product contains proportionally less DMT than clean crystal, so the same weight is a smaller dose. This cuts both ways, and the direction that hurts is moving from an uncleaned product to a well-recrystallised one without adjusting the amount.

Residual solvent is the other purity issue. Poorly dried extract can retain naphtha or heptane, which you will smell and should not inhale. Material with a chemical solvent smell needs re-drying rather than smoking.

What actually resolves it

Laboratory analysis is the only method that names the compound. DrugsData accepts anonymous mail-in samples in the United States, and in-person drug-checking services will identify tryptamines where they exist. For anything obtained as an unlabelled crystal from an unfamiliar source, and particularly for anything that might have come from Anadenanthera seed material, this is worth the delay.

Changa cannot be verified in any useful way, since the DMT content is a proportion of a herb blend and there is no way to establish it at home.

Legal Status

DMT is scheduled as a controlled substance in most jurisdictions globally, typically in the same class as psilocybin and LSD. In the United States it is Schedule I; in the UK, Class A; in Canada, Schedule III. Some countries’ scheduling of plant preparations containing DMT is distinct from scheduling the pure compound, legal nuances vary by jurisdiction. Ayahuasca’s legal status, being a plant preparation with cultural heritage dimensions, differs from that of extracted DMT in several countries. In Brazil, ayahuasca is legal for religious use, with downstream implications for its constituent compounds. In most jurisdictions, extracted DMT is illegal regardless of its plant origin.

If You Are Considering This

General preparation is on assessment, preparation, and integration. What is specific to smoked DMT is unusual, because the experience is over in fifteen minutes and almost everything that matters has to be arranged before it starts.

A sitter is not optional here

For several minutes you will be unresponsive, unable to speak, and unaware of the room. Someone sober needs to be present, and their job is largely physical: take the pipe out of your hands, make sure you stay where you are, and say nothing unless something is wrong. A lit glass pipe dropped by someone who has just left the room mentally is the most common way a DMT experience causes an injury, and it is entirely preventable by handing it over.

Be seated or lying down before you inhale

Not after. People stand up during onset, and they fall. Sit on the floor rather than a chair, or lie down, somewhere you cannot roll into anything hard. Take the same care you would for a general anaesthetic, because functionally that is closer to what is about to happen than a psychedelic dose is.

The half-dose is the worst outcome

The unusual feature of DMT dosing is that a partial dose is often more distressing than a full one. Someone who gets a third of the way there is anxious, disoriented, and aware that something large is happening without arriving anywhere. This is usually a technique problem rather than a quantity problem, and the administration notes matter more here than the numbers. Decide before you start whether you are doing this, and if you are, commit to the inhalations required rather than testing the water.

Brevity is not gentleness

Fifteen minutes of clock time is not fifteen minutes of experienced time, and there is no gradual onset in which to gather yourself. Preparation matters more with DMT rather than less, precisely because there is no opportunity to adjust once it begins. Have the room dark and quiet, have nothing scheduled afterwards, and give yourself an hour on the other side before speaking to anyone who was not there.

Confirm which compound you have

Everything above assumes N,N-DMT. If there is any doubt, resolve it before the day rather than during it, because the consequences of confusing it with 5-MeO-DMT are severe and no home test will catch the error.

DMT asks for very little time and a great deal of arrangement. Get the room, the sitter, and the identity of the compound settled, and the rest of it takes care of itself in a quarter of an hour.

Frequently Asked Questions